Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Association between dopamine beta-hydroxylase 19-bp insertion/deletion polymorphism and major depressive disorder.

Zhou Y, Wang J, He Y, Zhou J, Xi Q, Song X, Ye Y, Ying B.

J Mol Neurosci. 2015 Feb;55(2):367-71. doi: 10.1007/s12031-014-0339-y.

PMID:
24888991
2.

Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.

Hui L, Zhang X, Yu YQ, Han M, Huang XF, Chen DC, Wang ZR, Du WL, Kou CG, Yu Q, Kosten TR, Zhang XY.

Schizophr Res. 2013 Jul;147(2-3):236-40. doi: 10.1016/j.schres.2013.04.035.

PMID:
23707643
3.

The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia.

Hui L, Zhang X, Huang XF, Han M, Fernandez F, Yu Y, Sun S, Li W, Chen DC, Xiu MH, Kosten TR, Zhang XY.

J Psychiatr Res. 2012 Jun;46(6):733-7. doi: 10.1016/j.jpsychires.2012.02.016.

PMID:
22445279
4.

Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.

Hui L, Han M, Huang XF, Ye MJ, Zheng K, He JC, Lv MH, Zhang BH, Soares JC, Zhang XY.

J Neural Transm (Vienna). 2015 Jun;122(6):907-14. doi: 10.1007/s00702-014-1327-7.

PMID:
25336319
5.

Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.

Hui L, Han M, Yin GZ, Zhang Y, Huang XF, Qian ZK, Gu WG, Gu XC, Zhu XM, Soares JC, Ning Y, Zheng Y, Du XD, Zhang XY.

Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30472-8. doi: 10.1016/j.schres.2016.10.028. [Epub ahead of print]

PMID:
27776953
6.

Association between 1603C>T polymorphism of DBH gene and bipolar disorder in a Turkish population.

Ates O, Celikel FC, Taycan SE, Sezer S, Karakus N.

Gene. 2013 May 1;519(2):356-9. doi: 10.1016/j.gene.2013.01.031.

PMID:
23384717
7.

Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.

Zhou N, Yu Q, Li X, Yu Y, Kou C, Li W, Xu H, Luo X, Zuo L, Kosten TR, Zhang XY.

Hum Psychopharmacol. 2013 May;28(3):230-7. doi: 10.1002/hup.2311.

PMID:
23559427
8.

Association between DβH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.

Hui L, Han M, Huang XF, Ye MJ, Zhang X, He JC, Lv MH, Soares JC, Zhang XY.

J Clin Psychiatry. 2016 Mar;77(3):379-85. doi: 10.4088/JCP.14m09629.

PMID:
26891013
9.

Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study.

Yamamoto K, Cubells JF, Gelernter J, Benkelfat C, Lalonde P, Bloom D, Lal S, Labelle A, Turecki G, Rouleau GA, Joober R.

Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):33-8.

PMID:
12555232
10.

Association study between the -1021C/T polymorphism of the dopamine-beta-hydroxylase gene promoter and personality traits in healthy subjects.

Kamata M, Suzuki A, Matsumoto Y, Shibuya N, Togashi H, Goto K, Otani K.

Neurosci Lett. 2009 Oct 2;462(1):54-7. doi: 10.1016/j.neulet.2009.06.077.

PMID:
19560519
11.

Genetic marker of norepinephrine synthesis predicts individual differences in post-error slowing: a pilot study.

Colzato LS, de Rover M, van den Wildenberg WP, Nieuwenhuis S.

Neuropsychologia. 2013 Nov;51(13):2600-4. doi: 10.1016/j.neuropsychologia.2013.07.026.

PMID:
23962674
13.

[Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder].

Zhang HB, Wang YF, Li J, Wang B, Yang L.

Zhonghua Er Ke Za Zhi. 2005 Jan;43(1):26-30. Chinese.

PMID:
15796803
14.

A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.

Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch KP, Jacob CP.

J Neural Transm (Vienna). 2009 Feb;116(2):121-30. doi: 10.1007/s00702-008-0138-0.

PMID:
18982239
15.

Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population.

He M, Yan H, Duan ZX, Qu W, Gong HY, Fan ZL, Kang JY, Li BC, Wang JM.

Int J Clin Exp Pathol. 2013 May 15;6(6):1142-9.

16.

The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.

Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R.

Cancer Epidemiol. 2013 Oct;37(5):634-8. doi: 10.1016/j.canep.2013.05.007.

PMID:
23806437
17.

The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.

Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S.

Cancer Biomark. 2016;16(1):109-15. doi: 10.3233/CBM-150546.

PMID:
26835711
18.

Association of dopamine beta-hydroxylase polymorphism with hypertension through interaction with fasting plasma glucose in Japanese.

Abe M, Wu Z, Yamamoto M, Jin JJ, Tabara Y, Mogi M, Kohara K, Miki T, Nakura J.

Hypertens Res. 2005 Mar;28(3):215-21.

PMID:
16097364
19.

Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.

Laaribi AB, Zidi I, Hannachi N, Ben Yahia H, Chaouch H, Bortolotti D, Zidi N, Letaief A, Yacoub S, Boudabous A, Rizzo R, Boukadida J.

J Viral Hepat. 2015 Oct;22(10):835-41. doi: 10.1111/jvh.12395.

PMID:
25619305
20.

Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura.

Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR.

J Neurol Sci. 2006 Dec 21;251(1-2):118-23.

PMID:
17095019
Items per page

Supplemental Content

Support Center